Akèy › Pwoblèm Je Dyabetik › Alabama
Etid klinik pou Pwoblèm Je Dyabetik nan Alabama
3 etid pou Pwoblèm Je Dyabetik ap chèche patisipan nan sit nan Alabama.
Vil nan Alabama
Tèks ofisyèl etid la (Anglè)
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 98 · Tout sèks · Mizajou Sep 28, 2026 · NCT03403686Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
- University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 98 · Tout sèks · Mizajou Jan 22, 2026 · NCT03403699Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
- Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 29, 2025 · NCT06629649Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.